Subscribe

Kobayashi Pharmaceutical Co., Ltd. (4967.T)

JPY5,526.00 -43.00 (-0.77%)
JP JPX Consumer Defensive Household & Personal Products
Address KDX Kobayashi Doshomachi Building 541-0045
Osaka, JP
CEO Akihiro Kobayashi
Website kobayashi.co.jp
IPO 2001-01-04
ISIN JP3301100008

Explore sections of this company profile

Also trades on Other OTC · KBYPF (USD) Tokyo Stock Exchange · 4967.T (JPY)
Description

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air fresheners, lens cleaners, and oral hygiene products. It also manufactures and sells pharmaceuticals, fragrances, deodorants, cosmetics, health food, synthetic resin processed products, paper products, and hand warmers; and sells daily necessities. In addition, the company engages in transportation, real estate management, advertising planning and production, sales promotion and market research, promotional goods production and sales, and asset management activities, as well as in pharmacy, retail, and cleaning industries. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
JPY5,526.00 -43.00 (-0.77%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
233.8K
Beta
0.26
Float Shares
47.57M
Free Float %
64.0%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.32% +1.17% -0.73% +6.85% +7.85% +9.78% +12.13% -28.87% -39.82% +32.61% +269.44%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
5,526.00
DCF (Unlevered) 6,987.14 +26.4%
DCF (Levered) 4,206.86 -23.9%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 25% Bullish
Rating 2026-05 Change
Strong Buy 1 0
Buy 1 0
Hold 4 0
Sell 1 0
Strong Sell 1 0
Quality scores
Altman Z-Score
7.82
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
B-
Overall Score
3 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
2 / 5
Medium
ROA Score
3 / 5
Medium
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
  • ✗
    Revenue growth Household & Personal Products: +3.3%
    +0.1% Q1'26: +3.2% (vs Q1'25)
  • ✗
    EPS growth Household & Personal Products: +8.8%
    -63.7% Q1'26: -36.2% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Household & Personal Products: +44.8%
    +6.9% ★ Q1'26: +0.0% (vs Q1'25)
  • ✗
    EBIT margin Household & Personal Products: +9.9%
    +2.3% Q1'26: +4.0% (vs Q1'25)
  • ✗
    ROIC Household & Personal Products: +8.2%
    +2.6% Q1'26: +2.2% (vs Q1'25)
  • ✓
    Share dilution Household & Personal Products: +0.2%
    +0.0% Q1'26: 0.0% (vs Q1'25)
  • ✓
    Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×
    0.05× ★ Q1'26: 0.13× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.01) × ERP
WACC = 100% × Ke + 0% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 6,987.27 Current price: 5,526.00
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2014
actual 		Dec 2015
actual 		Dec 2016
actual 		Dec 2016
actual 		Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
7 Rev. Ana.
8 EPS Ana. 		Dec 2027
7 Rev. Ana.
7 EPS Ana. 		Dec 2028
6 Rev. Ana.
6 EPS Ana. 		Dec 2029
5 Rev. Ana.
4 EPS Ana. 		Dec 2030
3 Rev. Ana.
2 EPS Ana.
Revenue
127.29B
est: 129.58B (-1.8%)
128.34B
est: 135.96B (-5.6%)
137.21B
est: 117.92B (+16.4%)
152.65B
est: 117.92B (+29.5%)
156.76B
est: 155.82B (+0.6%)
167.48B
est: 167.16B (+0.2%)
168.05B
est: 170.25B (-1.3%)
150.51B
est: 154.08B (-2.3%)
155.25B
est: 156.91B (-1.1%)
166.26B
est: 164.10B (+1.3%)
173.46B
est: 172.97B (+0.3%)
165.60B
est: 167.58B (-1.2%)
165.74B
est: 165.38B (+0.2%)
173.38B
172.02B – 176.19B
+4.8% YoY
180.74B
177.01B – 186.72B
+4.2% YoY
187.17B
186.97B – 187.37B
+3.6% YoY
191.56B
188.81B – 196.32B
+2.3% YoY
198.16B
195.32B – 203.09B
+3.4% YoY
EBITDA
22.78B
est: 24.38B (-6.6%)
23.17B
est: 25.58B (-9.4%)
21.86B
est: 22.19B (-1.5%)
24.38B
est: 22.19B (+9.9%)
26.13B
est: 29.32B (-10.9%)
28.74B
est: 31.45B (-8.6%)
30.95B
est: 32.03B (-3.4%)
30.76B
est: 28.99B (+6.1%)
32.49B
est: 29.52B (+10.0%)
33.33B
est: 30.87B (+7.9%)
33.65B
est: 28.08B (+19.8%)
21.96B
est: 27.21B (-19.3%)
12.52B
est: 26.85B (-53.4%)
28.15B
27.93B – 28.61B
+4.8% YoY
29.35B
28.74B – 30.32B
+4.2% YoY
30.39B
30.36B – 30.42B
+3.6% YoY
31.10B
30.66B – 31.88B
+2.3% YoY
32.17B
31.71B – 32.97B
+3.4% YoY
EBIT
19.69B
est: 19.87B (-0.9%)
20.08B
est: 20.85B (-3.7%)
18.79B
est: 18.08B (+3.9%)
20.88B
est: 18.08B (+15.5%)
22.61B
est: 23.89B (-5.4%)
25.34B
est: 25.63B (-1.1%)
26.82B
est: 26.11B (+2.8%)
26.66B
est: 23.63B (+12.8%)
27.65B
est: 24.06B (+14.9%)
27.97B
est: 25.16B (+11.1%)
27.59B
est: 21.18B (+30.2%)
13.94B
est: 20.52B (-32.1%)
3.77B
est: 20.25B (-81.4%)
21.23B
21.07B – 21.58B
+4.8% YoY
22.13B
21.68B – 22.87B
+4.2% YoY
22.92B
22.90B – 22.95B
+3.6% YoY
23.46B
23.12B – 24.04B
+2.3% YoY
24.27B
23.92B – 24.87B
+3.4% YoY
Net Income
12.31B
est: 11.48B (+7.2%)
12.45B
est: 12.61B (-1.3%)
13.47B
est: 13.25B (+1.6%)
15.33B
est: 13.25B (+15.7%)
15.86B
est: 15.61B (+1.6%)
18.02B
est: 17.08B (+5.5%)
19.14B
est: 18.46B (+3.7%)
19.21B
est: 18.70B (+2.7%)
19.72B
est: 18.79B (+4.9%)
20.02B
est: 19.31B (+3.7%)
20.34B
est: 13.91B (+46.2%)
10.07B
est: 11.07B (-9.1%)
3.66B
est: 11.64B (-68.6%)
10.60B
9.86B – 11.64B
-9.0% YoY
13.97B
12.01B – 16.86B
+31.8% YoY
17.14B
14.13B – 19.98B
+22.7% YoY
18.04B
17.70B – 18.62B
+5.3% YoY
19.24B
18.88B – 19.86B
+6.7% YoY
SGA
48.66B
est: 31.75B (+53.3%)
48.96B
est: 33.31B (+47.0%)
36.08B
est: 28.89B (+24.9%)
58.02B
est: 28.89B (+100.8%)
63.54B
est: 38.18B (+66.4%)
68.12B
est: 40.95B (+66.3%)
68.00B
est: 41.71B (+63.0%)
50.25B
est: 37.75B (+33.1%)
52.19B
est: 38.44B (+35.8%)
54.07B
est: 40.21B (+34.5%)
57.61B
est: 55.75B (+3.3%)
48.19B
est: 54.01B (-10.8%)
54.21B
est: 53.30B (+1.7%)
55.88B
55.44B – 56.79B
+4.8% YoY
58.25B
57.05B – 60.18B
+4.2% YoY
60.33B
60.26B – 60.39B
+3.6% YoY
61.74B
60.85B – 63.28B
+2.3% YoY
63.87B
62.95B – 65.46B
+3.4% YoY
EPS
150.28
est: 154.46 (-2.7%)
152.72
est: 169.61 (-10.0%)
165.55
est: 178.26 (-7.1%)
191.42
est: 178.26 (+7.4%)
201.31
est: 210.02 (-4.1%)
228.04
est: 229.83 (-0.8%)
244.07
est: 248.38 (-1.7%)
245.70
est: 251.62 (-2.4%)
252.35
est: 252.78 (-0.2%)
259.61
est: 257.55 (+0.8%)
268.16
est: 185.56 (+44.5%)
135.42
est: 147.92 (-8.5%)
49.18
est: 155.58 (-68.4%)
142.65
132.62 – 156.52
-8.3% YoY
187.49
161.57 – 226.79
+31.4% YoY
230.35
190.04 – 268.79
+22.9% YoY
242.65
238.12 – 250.49
+5.3% YoY
258.85
254.01 – 267.21
+6.7% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-08 B- 3/5 3/5 2/5 3/5 3/5 1/5 3/5
2026-05-07 B- 3/5 3/5 2/5 3/5 3/5 1/5 3/5
2026-05-01 B- 3/5 3/5 2/5 3/5 3/5 1/5 3/5
2026-04-30 B- 3/5 3/5 2/5 3/5 3/5 1/5 3/5
2026-04-28 B- 3/5 3/5 2/5 3/5 3/5 1/5 3/5
2026-04-27 B 3/5 3/5 2/5 4/5 3/5 1/5 3/5
2026-04-24 B 3/5 3/5 2/5 4/5 3/5 1/5 3/5
2026-04-23 B 3/5 3/5 2/5 4/5 3/5 1/5 3/5
2026-04-22 B 3/5 3/5 2/5 4/5 3/5 1/5 3/5
2026-04-21 B 3/5 3/5 2/5 4/5 3/5 1/5 3/5
2026-04-20 B 3/5 3/5 2/5 4/5 3/5 1/5 3/5
2026-04-17 B 3/5 3/5 2/5 4/5 3/5 1/5 3/5
2026-04-16 B 3/5 3/5 2/5 4/5 3/5 1/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-484.43M
OE per share TTM
-6.64
Owner's Yield
-0.11%
Maintenance CapEx ratio
13.79%
Maint CapEx / Avg PPE
20.4%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 92 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 State Street SPDR S&P Pan Asia Dividend Aristocrats UCITS ETF (Dist) ASDV.L 0.39% 937.7K 0.55%
2 iShares MSCI Japan Small Cap UCITS ETF IDJP.L 0.13% 729.8K 0.58%
3 iShares MSCI Japan Small-Cap ETF SCJ 0.13% 330.4K 0.50%
4 Schwab Fundamental International Small Company Index ETF FNDC 0.06% 1.69M 0.39%
5 BMO Global Consumer Staples Hedged to CAD Index ETF STPL.TO 0.05% 11.3K 0.40%
6 iShares Currency Hedged MSCI EAFE Small-Cap ETF HSCZ 0.05% 108.0K 0.83%
7 iShares MSCI EAFE Small-Cap ETF SCZ 0.05% 6.51M 0.40%
8 iShares JPX-Nikkei 400 ETF JPXN 0.05% 62.1K 0.48%
9 Invesco JPX-Nikkei 400 UCITS ETF NS4E.DE 0.04% 76.3K 0.19%
10 Invesco JPX-Nikkei 400 UCITS ETF N400.L 0.04% 76.3K 0.19%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
1.01M
Shares Outstanding
74.34M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Atsushi Onoyama Managing Exec Offc., Head of the Marketing Div & GM of Household Products Glob. Dept - Household Div — —
Atsushi Uenohara Corporate Communications Department — —
Fujito Ohwaki Managing Executive Officer & GM of Healthcare Division — male
Kazuki Kuriyama Manager of Investor Relations — —
Kei Sato Executive Officer & Head of Compensation Division — —
Keisuke Kajita Head of Food Section of Health Care Department — male
Kenji Kobori Executive Officer & Head of Sales Headquarters — —
Ryo Ishido Executive Officer & CDO Unit Head — male
Takayuki Kimura General Manager of General Affairs Department & Human Resources Dept — —
Yuji Matsushima Managing Exe. Off., GM of R&D Div. & New Market Creation R&D dept. and Director — —
Yuko Tomiyama Officer of Corporate Communication & Investor Relations — —
Yumi Nakagawa Executive Officer & Chief of Finance — female
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Household & Personal Products